C. de Roquetaillade

发表

Role of Damage-Associated Molecular Patterns in Septic Acute Kidney Injury, From Injury to Recovery

A. Mebazaa, J. Pottecher, B. Chousterman, 2021, Frontiers in Immunology.

Systemic Inflammation Evaluated by Interleukin-6 or C-Reactive Protein in Critically Ill Patients: Results From the FROG-ICU Study

A. Mebazaa, E. Gayat, M. Sadoune, 2022, Frontiers in Immunology.

Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients

A. Mebazaa, A. Kimmoun, B. Chousterman, 2021, Journal of Critical Care.

Immunotherapy to treat sepsis induced-immunosuppression: Immune eligibility or outcome criteria, a systematic review.

A. Mebazaa, B. Chousterman, Romain Barthélémy, 2022, Journal of critical care.

Unusual arterial thrombotic events in Covid-19 patients

A. Mebazaa, M. Metra, G. Montalescot, 2020, International Journal of Cardiology.

Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery

A. Mebazaa, E. Gayat, B. Chousterman, 2020, British Journal of Anaesthesia.

Timing and causes of death in severe COVID-19 patients

T. Soumagne, F. Pène, A. Stoclin, 2021, Critical Care.

Could host response guide VAP treatment? No answer yet.

B. Chousterman, C. de Roquetaillade, S. Mansouri, 2020, The Lancet. Respiratory medicine.

Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: relation with secondary infections

C. Dupuis, A. Lukaszewicz, C. Brumpt, 2022, Annals of Intensive Care.

Making things right! Shouldn't we screen patients with thromboembolic events for SARS-CoV-2 infection, during the pandemia?

A. Mebazaa, B. Chousterman, C. de Roquetaillade, 2021, International Journal of Cardiology.

Beta-Blockers in COVID-ARDS

B. Chousterman, Romain Barthélémy, C. de Roquetaillade, 2022, Journal of the American College of Cardiology.

Making things right! Shouldn't we screen patients with thromboembolic events for SARS-CoV-2 infection, during the pandemia?

A. Mebazaa, B. Chousterman, C. de Roquetaillade, 2021, International Journal of Cardiology.

Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients

A. Mebazaa, B. Mégarbane, E. Gayat, 2020, Journal of Infection.

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

A. Mebazaa, D. Annane, J. Chiche, 2020, Intensive Care Medicine.

Hemodynamic Impact of Cardiovascular Antihypertensive Medications in Patients With Sepsis-Related Acute Circulatory Failure.

J. Chiche, J. Mira, A. Cariou, 2020, Shock.

Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network—the ProneCOVID study

A. Mebazaa, D. Annane, J. Chiche, 2022, Critical Care.

Omicron variants of the SARS-COV-2: A potentially significant threat in a new wave of infections

K. Batra, L. Szarpak, Francesco Chirico, 2022, Disaster and Emergency Medicine Journal.

Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective Study

O. Mir, L. Argaud, L. Le Guennec, 2022, Frontiers in Oncology.

Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients

F. Peacock, L. Szarpak, Francesco Chirico, 2023, Annals of medicine.

Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: relation with outcome and secondary infections.

D. Payen, C. Dupuis, A. Lukaszewicz, 2020, medRxiv.

Cytokine profiles in adults with imported malaria: insights from the PALUREA cohort study

J. Timsit, J. Mira, F. Raffi, 2022, bioRxiv.

Two New Neutrophil Subsets Define a Discriminating Sepsis Signature.

Sierra M. Barone, S. Granjeaud, J. Irish, 2021, American journal of respiratory and critical care medicine.

Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study

A. Mebazaa, D. Annane, J. Chiche, 2021, Annals of intensive care.

Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores

A. Mebazaa, D. Annane, J. Chiche, 2021, Annals of Intensive Care.

Comparison of Circulating Immune Cells Profiles and Kinetics Between Coronavirus Disease 2019 and Bacterial Sepsis*

A. Mebazaa, B. Mégarbane, E. Gayat, 2021, Critical care medicine.

Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals

A. Mebazaa, D. Annane, J. Chiche, 2021, Critical Care.

Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study

A. Mebazaa, D. Annane, J. Chiche, 2021, Annals of Intensive Care.

Pulmonary infections prime the development of subsequent ICU-acquired pneumonia in septic shock

J. Chiche, J. Mira, A. Cariou, 2019, Annals of Intensive Care.

Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study

A. Mebazaa, D. Annane, J. Chiche, 2023, Critical Care.

IL-7 and Its Beneficial Role in Sepsis-Induced T Lymphocyte Dysfunction.

F. Venet, G. Monneret, C. de Roquetaillade, 2018, Critical reviews in immunology.

Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU

A. Mebazaa, M. Antonelli, T. Beeker, 2020, Critical Care.

Cytokine profiles in adults with imported malaria

J. Timsit, J. Mira, F. Raffi, 2023, Scientific reports.

Intracellular calcium signaling and phospho-antigen measurements reveal functional proximal TCR activation in lymphocytes from septic shock patients

T. Rimmele, L. Argaud, M. Cour, 2019, Intensive Care Medicine Experimental.